NoCamels publishes article on the benefits of nociception monitoring with the NOL Technology
The Israel Tech & Innovation Media site NoCamels publishes article about NOL
The Israel Tech & Innovation Media site NoCamels publishes article about NOL
The chronic pain news service, Pain News Network, featured an interview given by Medasense CEO Galit Zuckerman Stark
Agency clearance paves way for commercialization in the United States of first and only authorized device to measure pain in anesthetized patients undergoing surgery
Agency clearance paves way for commercialization in the United States of first and only authorized device to measure pain in anesthetized patients undergoing surgery
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to reduce postoperative pain.
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to reduce postoperative pain.
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to detect pain response levels in ICU patients.
New study shows that effective opioid-sparing anaesthesia with dexmedetomidine can be guided with NOL pain monitoring technology.
Press release: Monitoring pain response levels during surgery with NOL technology can help reduce postoperative pain as well as healthcare costs.
NOL pain response monitoring has been approved for marketing in Brazil.